Interim Results of a Phase I/II Trial of Intermediate-Dose Post-Transplantation Cyclophosphamide after Reduced Intensity Conditioned HLA-Mismatched Bone Marrow Transplantation for Older or Unfit Patients
Shannon R. McCurdy, Mustafa Hyder, Ruby Sabina, Ashley DeVries, Kirstin Chalupa, Natasha Berryman, Jessica Bernhardt, Alison Christina Cusmano, Amy Chai, Rebecca M. Schwartz, Dimana Dimitrova, Kamil Rechache, Christi McKeown, Anita Stokes, Jennifer Sponaugle, Noelle V. Frey, Saar Gill, Elizabeth O. Hexner, Mary Ellen Martin, Nasheed Hossain, David Porter, Alison W. Loren, Jennifer A. Kanakry, Christopher G. Kanakry
Topics & Concepts
MedicineCyclophosphamideInterimTransplantationBone marrow transplantationHuman leukocyte antigenIntensity (physics)Internal medicineSurgeryOncologyChemotherapyImmunologyQuantum mechanicsAntigenArchaeologyHistoryPhysicsHematopoietic Stem Cell TransplantationMultiple Sclerosis Research StudiesRenal Transplantation Outcomes and Treatments